10.1378/chest.12-2664 [DOI] [PubMed] [Google Scholar] 80.Zinellu E, Zinellu A, Pau MC, Piras B, Fois AG, Mellino S, et al
GLP-1 medication changes may support long-term weight management Patients who switch obesity drugs after less than a year stay better engaged with their treatment, UTSW researchers find DALLAS March 10, 2026 Patients without diabetes who switched GLP-1 receptor agonist (GLP-1RA) drugs for overweight or obesity were more likely to stick with their treatment longer than those who didnt switch, according to a new study by UT Southwestern Medical Center researchers
If you still feel under-fuelled during sessions, the 3300mg liquid format could be your next step
Active form (GSH) is antidamage form and a cell form
However, the drug is being offered only for two years and only in specialist services - raising issues of fairness